Table 4: Plasma variables of Tables 3(c) and 3(d) with significant differences between EET and SED individuals at baseline (pre). Displayed are the relative treatment effects (RTEs) and their corresponding 95% confidence intervals (CI). and indicate significant differences between groups. EET: endurance-exercise-trained; SED: untrained/sedentary.

VariableGroupRTE (CI) pre

AATEET0.55 (0.45; 0.65)
SED0.35 (0.27; 0.43)

B2MEET0.48 (0.39; 0.57)
SED0.26 (0.2; 0.34)

CK-MBEET0.54 (0.45; 0.62)
SED0.27 (0.21; 0.35)

GHEET0.37 (0.31; 0.43)
SED0.22 (0.17; 0.29)

IL-3EET0.63 (0.54; 0.71)
SED0.34 (0.26; 0.44)

IL-7EET0.59 (0.5; 0.67)
SED0.36 (0.27; 0.47)

MCP-1EET0.52 (0.42; 0.61)
SED0.28 (0.21; 0.37)

TNFR2EET0.54 (0.45; 0.63)
SED0.32 (0.24; 0.42)

VCAM-1EET0.53 (0.44; 0.63)
SED0.33 (0.26; 0.42)

AAT = alpha-1-antitrypsin; B2M = Beta 2 Microglobulin; GH = growth hormone; IL-3 = interleukin-3; IL-7 = interleukin-7; IL-8 = interleukin-8; IL-10 = interleukin-10; IL-13 = interleukin-13; MCP-1 = monocyte chemotactic protein-1; TNF-α = tumor necrosis factor-alpha; TNFR2 = tumor necrosis factor receptor 2; VCAM-1 = Vascular Cell Adhesion Molecule-1.